RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Unraveling SNAP: distinct patterns of early neurodegeneration through MRI texture analysis

Neuroimage Clin 47:103829 · 2025 · PMID 40540876

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

231편 검색→224편 판독→138편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Suspected non-Alzheimer disease pathophysiology and neurodegeneration on MRI ("suspected non-Alzheimer* pathophysiology"[tiab] OR "SNAP"[tiab] OR "non-Alzheimer*"[tiab] OR "non-AD"[tiab]) AND (neurodegenerat*[tiab] OR "neuronal injury"[tiab] OR atrophy[tiab] OR "neuronal loss"[tiab]) AND ("magnetic resonance imaging"[tiab] OR MRI[tiab] OR "magnetic resonance"[tiab])

출판 연도

1993: 1편119931997: 1편12000: 2편220002002: 1편12003: 1편12004: 2편220052007: 1편12008: 2편22009: 3편32010: 2편220102012: 2편22013: 3편32014: 2편22015: 3편320152016: 8편82017: 5편52018: 6편62019: 6편62020: 10편1020202021: 10편102022: 14편142023: 9편92024: 13편132025: 18편182026: 13편132026

선별된 138편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01snap · amyloid42편

  1. 0.95

    Unraveling SNAP: distinct patterns of early neurodegeneration through MRI texture analysis 이 논문

    Kwon MJ, Park J, Jo S et al. · NeuroImage. Clinical · 2025

  2. 0.93

    Distinct Brain Functional Impairment Patterns Between Suspected Non-Alzheimer Disease Pathophysiology and Alzheimer's Disease: A Study Combining Static and Dynamic Functional Magnetic Resonance Imaging

    Li Z, Li K, Luo X et al. · Frontiers in aging neuroscience · 2020

  3. 0.93

    Pathological drivers of neurodegeneration in suspected non-Alzheimer's disease pathophysiology

    Wisse LEM, de Flores R, Xie L et al. · Alzheimer's research & therapy · 2021

  4. 0.93

    Cerebrovascular disease in suspected non-Alzheimer's pathophysiology and cognitive decline over time

    Saridin FN, Chew KA, Reilhac A et al. · European journal of neurology · 2022

  5. 0.92

    Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression

    Caroli A, Prestia A, Galluzzi S et al. · Neurology · 2015

  6. 0.92

    Differential atrophy along the longitudinal axis of the hippocampus in Alzheimer's disease and suspected non-Alzheimer's disease pathophysiology (SNAP)

    Meira T, Morais-Ribeiro R, Jesus T et al. · Neuroradiology · 2026

  7. 0.92

    Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

    Schreiber S, Schreiber F, Lockhart SN et al. · JAMA neurology · 2017

  8. 0.89

    Longitudinal beta-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology

    Gordon BA, Blazey T, Su Y et al. · JAMA neurology · 2016

  9. 0.89

    Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study

    Burnham SC, Bourgeat P, Dore V et al. · The Lancet. Neurology · 2016

  10. 0.89

    Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau

    McCollum LE, Das SR, Xie L et al. · NeuroImage. Clinical · 2021

  11. 0.88

    In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics

    Tahmi M, Rippon B, Palta P et al. · Journal of Alzheimer's disease : JAD · 2021

  12. 0.88

    Longitudinal Spatial Relationships Between Atrophy and Hypometabolism Across the Alzheimer's Disease Continuum

    Stocks J, Heywood A, Popuri K et al. · Journal of Alzheimer's disease : JAD · 2023

  13. 0.88

    Amyloid beta Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia

    Zhao Y, Tudorascu DL, Lopez OL et al. · JAMA neurology · 2018

  14. 0.88

    Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type

    Lagarde J, Olivieri P, Tonietto M et al. · Translational psychiatry · 2021

  15. 0.87

    Cerebral amyloid-beta, glucose metabolism and hippocampal volume in major depression with and without suspected non-Alzheimer pathophysiology (SNAP)

    Wu MJ, Hsiao IT, Lin KJ et al. · Alzheimer's research & therapy · 2025

  16. 0.86

    Disease trajectories in elders with suspected non-Alzheimer's pathophysiology and its comparison with Alzheimer's disease pathophysiology: a longitudinal study

    Li JQ, Song JH, Suckling J et al. · Research square · 2023

  17. 0.85

    Clinical and cortical decline in the aphasic variant of Alzheimer's disease

    Rogalski EJ, Sridhar J, Martersteck A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019

  18. 0.85

    Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals

    Mormino EC, Betensky RA, Hedden T et al. · JAMA neurology · 2014

  19. 0.85

    Network-wise concordance of multimodal neuroimaging features across the Alzheimer's disease continuum

    Stocks J, Popuri K, Heywood A et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2022

  20. 0.84

    Differences in cognitive performance and neuroanatomy according to Alzheimer's disease pathophysiology

    Ribeiro IC, Goncalves BC, Aventurato IK et al. · Arquivos de neuro-psiquiatria · 2026

  21. 0.83

    Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults

    Hanseeuw BJ, Jacobs HIL, Schultz AP et al. · Neurology · 2023

  22. 0.83

    NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers

    Vos SJB, Gordon BA, Su Y et al. · Neurobiology of aging · 2016

  23. 0.82

    Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study

    Jack CRJ, Therneau TM, Wiste HJ et al. · The Lancet. Neurology · 2016

  24. 0.82

    The Association of Multimorbidity With Preclinical AD Stages and SNAP in Cognitively Unimpaired Persons

    Vassilaki M, Aakre JA, Kremers WK et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2019

  25. 0.82

    Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

    Jack CRJ, Wiste HJ, Weigand SD et al. · Neurology · 2013

  26. 0.82

    Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife

    Racine AM, Koscik RL, Berman SE et al. · Brain : a journal of neurology · 2016

  27. 0.81

    Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer's Disease Neuroimaging Initiative

    Allegri RF, Chrem Mendez P, Calandri I et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2020

  28. 0.81

    Decreased Cerebral Amyloid-beta Depositions in Patients With a Lifetime History of Major Depression With Suspected Non-Alzheimer Pathophysiology

    Wu KY, Lin KJ, Chen CH et al. · Frontiers in aging neuroscience · 2022

  29. 0.80

    Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study

    Jack CRJ, Wiste HJ, Weigand SD et al. · The Lancet. Neurology · 2017

  30. 0.80

    A Comprehensive Visual Rating Scale for Predicting Progression from Mild Cognitive Impairment to Dementia in Patients with Alzheimer's Pathology or Suspected Non-Alzheimer's Pathology

    Park SW, Kim S, Park J et al. · Dementia and neurocognitive disorders · 2020

  31. 0.78

    ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project

    Ebenau JL, Timmers T, Wesselman LMP et al. · Neurology · 2020

  32. 0.78

    Amyloid-beta levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy

    Oberstein TJ, Schmidt MA, Florvaag A et al. · Brain : a journal of neurology · 2022

  33. 0.77

    APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease

    Hohman TJ, Dumitrescu L, Oksol A et al. · PloS one · 2017

  34. 0.76

    Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort

    Ingala S, De Boer C, Masselink LA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021

  35. 0.74

    Prognostic value of imaging-based ATN profiles in a memory clinic cohort

    Peretti DE, Ribaldi F, Scheffler M et al. · European journal of nuclear medicine and molecular imaging · 2023

  36. 0.73

    Exploring the ATN classification system using brain morphology

    Heinzinger N, Maass A, Berron D et al. · Alzheimer's research & therapy · 2023

  37. 0.73

    Biomarkers of Alzheimer's disease in mild cognitive impairment: Experience in a memory clinic from Latin America

    Allegri RF, Chrem Mendez P, Russo MJ et al. · Neurologia · 2021

  38. 0.71

    Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer's disease patients

    Matsuda H, Hanyu H, Kaneko C et al. · Annals of nuclear medicine · 2025

  39. 0.68

    The A/T/N model applied through imaging biomarkers in a memory clinic

    Dodich A, Mendes A, Assal F et al. · European journal of nuclear medicine and molecular imaging · 2020

  40. 0.67

    PASSED: Brain atrophy in non-demented individuals in a long-term longitudinal study from two independent cohorts

    Haas AL, Olm P, Utz J et al. · Frontiers in aging neuroscience · 2023

  41. 0.62

    Association of Depressive Symptoms and Cognition in Older Adults Without Dementia Across Different Biomarker Profiles

    Rubin-Norowitz M, Lipton RB, Petersen K et al. · Journal of Alzheimer's disease : JAD · 2022

  42. 0.60

    Longitudinal change in ATN biomarkers in cognitively normal individuals

    Ebenau JL, Visser D, Kroeze LA et al. · Alzheimer's research & therapy · 2022

02syndrome · diagnosed20편

  1. 0.91

    Detecting limbic predominant neurodegenerative co-pathologies in vivo in Alzheimer's disease: magnetic resonance imaging markers, cognitive correlates, and prognosis

    Richter N, Onur OA, Fink GR · Alzheimer's research & therapy · 2025

  2. 0.90

    Hippocampal subfield volumetry in corticobasal syndrome of diverse underlying pathologies

    Constantinides VC, Tentolouris-Piperas V, Paraskevas GP et al. · Journal of neurology · 2023

  3. 0.88

    Autopsy-proven patient with corticobasal degeneration presenting with visuo-constructive disorders as initial symptoms: How advanced MRI sequences can help clinical practice

    Salman Y, Huyghe L, Quenon L et al. · Journal of Alzheimer's disease : JAD · 2025

  4. 0.88

    Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons

    Yu L, Boyle PA, Dawe RJ et al. · Neurology · 2020

  5. 0.88

    Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers

    Vaughan DP, Jensen MT, Real R et al. · Brain : a journal of neurology · 2026

  6. 0.87

    Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy

    Staekenborg SS, Koedam ELGE, Henneman WJP et al. · Stroke · 2009

  7. 0.85

    Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease

    Lalive HM, Griffa A, Carlier S et al. · Journal of Alzheimer's disease : JAD · 2024

  8. 0.82

    Dysexecutive mild cognitive impairment associated to frontal atrophy: Case report

    Balthazar MLF, Damasceno BP · Dementia & neuropsychologia · 2008

  9. 0.82

    Bilateral temporal lobe volume reduction parallels cognitive impairment in progressive aphasia

    Andersen C, Dahl C, Almkvist O et al. · Archives of neurology · 1997

  10. 0.79

    A Case of Late-Onset Semantic Dementia With Right-Predominant Temporal Lobe Atrophy due to Primary Tauopathy

    Sudo Y, Tamura M, Nakayama K et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2025

  11. 0.79

    Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia

    Varma AR, Adams W, Lloyd JJ et al. · Acta neurologica Scandinavica · 2002

  12. 0.78

    Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy: Case Study

    Forrest SL, Tartaglia MC, Kim A et al. · Neurology · 2022

  13. 0.77

    Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome

    Jabbari E, Holland N, Chelban V et al. · JAMA neurology · 2020

  14. 0.77

    Mild cognitive impairment: same identity for different entities

    Serra L, Giulietti G, Cercignani M et al. · Journal of Alzheimer's disease : JAD · 2013

  15. 0.69

    PET-based classification of corticobasal syndrome

    Nakano Y, Shimada H, Shinotoh H et al. · Parkinsonism & related disorders · 2022

  16. 0.68

    Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: the Goteborg MCI study

    Eckerstrom C, Olsson E, Borga M et al. · Journal of the neurological sciences · 2008

  17. 0.63

    Early detection of fronto-temporal degeneration by clinical evaluation

    Filley CM, Cullum CM · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 1993

  18. 0.58

    Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes

    Richter N, Breidenbach L, Schmieschek MH et al. · Journal of Alzheimer's disease : JAD · 2025

  19. 0.53

    MRI of the 'Alzheimer syndrome'

    Henry-Feugeas MC · Journal of neuroradiology = Journal de neuroradiologie · 2007

  20. 0.51

    A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI

    Jessen F, Gur O, Block W et al. · Neurology · 2009

03mild cognitive · pet17편

  1. 0.88

    Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition

    Graff-Radford J, Gunter JL, Jones DT et al. · Neurology · 2019

  2. 0.86

    Clinical utility of diffusion MRI-derived measures of cortical microstructure in a real-world memory clinic setting

    Torso M, Fumagalli G, Ridgway GR et al. · Annals of clinical and translational neurology · 2024

  3. 0.78

    Integrated amyloid, neurodegeneration, and vascular biomarkers estimate the risk of dementia progression in mild cognitive impairment

    Lee WJ, Cho K, Kim GW · Journal of Alzheimer's disease : JAD · 2026

  4. 0.73

    Utility of Tau PET in the diagnostic work up of neurodegenerative dementia among Indian patients

    Gupta A, Tripathi M, Sharma V et al. · Journal of the neurological sciences · 2024

  5. 0.72

    Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders

    Leuzy A, Smith R, Ossenkoppele R et al. · JAMA neurology · 2020

  6. 0.69

    Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting

    Perani D, Cerami C, Caminiti SP et al. · European journal of nuclear medicine and molecular imaging · 2016

  7. 0.66

    Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration

    Tan CH, Bonham LW, Fan CC et al. · Brain : a journal of neurology · 2019

  8. 0.65

    MRI-based atrophy subtypes in a young memory clinic cohort: associations with clinical and biomarker profiles

    Zilioli A, Mohanty R, Rosenberg A et al. · Alzheimer's research & therapy · 2026

  9. 0.60

    Different Profiles of Spatial Navigation Deficits In Alzheimer's Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment

    Laczo M, Martinkovic L, Lerch O et al. · Frontiers in aging neuroscience · 2022

  10. 0.57

    Limited utility of imaging-based (N) markers in predicting cerebral spinal fluid Alzheimer's disease biomarker positivity in lecanemab-eligible mild cognitive impairment

    Kuroda T, Mori Y, Shoji D et al. · Frontiers in neurology · 2025

  11. 0.56

    A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease

    Senda M, Ishii K, Ito K et al. · The journal of prevention of Alzheimer's disease · 2021

  12. 0.55

    The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment

    Galluzzi S, Geroldi C, Ghidoni R et al. · Journal of neurology · 2010

  13. 0.55

    Markers of Alzheimer's disease in a population attending a memory clinic

    Frisoni GB, Prestia A, Zanetti O et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2009

  14. 0.52

    Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders

    Ossenkoppele R, Rabinovici GD, Smith R et al. · JAMA · 2018

  15. 0.52

    Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting

    Weise D, Tiepolt S, Awissus C et al. · Journal of Alzheimer's disease : JAD · 2015

  16. 0.51

    Incremental diagnostic value of 18F-Fluetemetamol PET in differential diagnoses of Alzheimer's Disease-related neurodegenerative diseases from an unselected memory clinic cohort

    Bao YW, Shea YF, Chiu PKC et al. · Scientific reports · 2022

  17. 0.50

    Spatial navigation deficits in early Alzheimer's disease: the role of biomarkers and APOE genotype

    Laczo M, Svacova Z, Lerch O et al. · Journal of neurology · 2025

04diagnosis · tdp-4315편

  1. 0.90

    Diverse limbic comorbidities cause limbic and temporal atrophy in lewy body disease

    Sakurai K, Kaneda D, Morimoto S et al. · Parkinsonism & related disorders · 2022

  2. 0.87

    Polypathologic Associations with Gray Matter Atrophy in Neurodegenerative Disease

    Phillips JS, Robinson JL, Cousins KAQ et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024

  3. 0.87

    Age at dementia diagnosis, subtype associations, and neuroimaging differentiation in Bangladesh: The CARED study

    Ranjan R, Kawnayn G, Yusuf MA et al. · PloS one · 2026

  4. 0.87

    Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe

    Nho K, Saykin AJ, Nelson PT · Journal of Alzheimer's disease : JAD · 2016

  5. 0.85

    Medial temporal lobe Tau-Neurodegeneration mismatch from MRI and plasma biomarkers identifies vulnerable and resilient phenotypes with AD

    Lyu X, Mundada NS, Brown CA et al. · medRxiv : the preprint server for health sciences · 2025

  6. 0.83

    Medial temporal lobe Tau-Neurodegeneration mismatch from structural imaging and plasma biomarkers

    Lyu X, Mundada NS, Brown CA et al. · Brain : a journal of neurology · 2026

  7. 0.83

    Tau-neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum

    Lyu X, Duong MT, Xie L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  8. 0.81

    Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease

    Lowe VJ, Lundt ES, Albertson SM et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019

  9. 0.80

    Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia

    Hu WT, McMillan C, Libon D et al. · Neurology · 2010

  10. 0.79

    Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation

    Teichmann M, Kas A, Boutet C et al. · Brain : a journal of neurology · 2013

  11. 0.79

    Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer's and Lewy body disease

    Duong MT, Das SR, Khandelwal P et al. · Brain : a journal of neurology · 2025

  12. 0.74

    Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations

    Spina S, Schonhaut DR, Boeve BF et al. · Neurology · 2017

  13. 0.70

    Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease

    Mohanty R, Ferreira D, Frerich S et al. · Neurology · 2022

  14. 0.66

    Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database

    Hedderich DM, Opfer R, Kruger J et al. · Journal of Alzheimer's disease : JAD · 2025

  15. 0.57

    Neuronal loss of the nucleus basalis of Meynert in primary progressive aphasia is associated with Alzheimer's disease neuropathological changes

    Schaeverbeke J, Tome SO, Ronisz A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

05csf · fluid15편

  1. 0.87

    Risk factors and clinical significance of neurodegenerative co-pathologies in symptomatic cerebral small vessel disease

    Arndt P, Pfister M, Perosa V et al. · Journal of neurology · 2025

  2. 0.86

    Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia

    Contarino VE, Siggillino S, Arighi A et al. · Journal of Alzheimer's disease : JAD · 2022

  3. 0.86

    Neuronal and glial dysfunction, white matter hyperintensities and cognition in ageing and Alzheimer's disease

    Lee AJ, Howard E, Saltiel N et al. · Brain communications · 2025

  4. 0.85

    Amyloid Abeta40 CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementia

    Andersen C, Jensen M, Lannfelt L et al. · Neuroreport · 2000

  5. 0.84

    Cognitive and Biomarker Signatures of Late-Onset Temporal Lobe Epilepsy: Toward Non-Alzheimer Neurodegenerative Mechanisms

    Casarini A, Ballerini A, Maramotti R et al. · Neurology · 2026

  6. 0.84

    Association between Klotho levels in cerebrospinal fluid and choroid plexus enlargement in neurodegeneration

    Sacchi L, Arcaro M, Bocca G et al. · Frontiers in aging neuroscience · 2025

  7. 0.84

    Exploring cognitive and neuroimaging profiles of dementia subtypes of individuals with dementia in the Democratic Republic of Congo

    Ikanga J, Patel SS, Schwinne M et al. · Frontiers in aging neuroscience · 2025

  8. 0.81

    The Role of Vascular Risk Factors in Biomarker-Based AT(N) Groups: A German-Dutch Memory Clinic Study

    Kucikiene D, Costa AS, Banning LCP et al. · Journal of Alzheimer's disease : JAD · 2022

  9. 0.79

    Exploring Cognitive and Neuroimaging Profiles of Dementia Subtypes of Individuals with Dementia in the Democratic Republic of Congo

    Ikanga J, Patel SS, Schwinne M et al. · medRxiv : the preprint server for health sciences · 2024

  10. 0.76

    Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging

    Nelson PT, Katsumata Y, Nho K et al. · Acta neuropathologica · 2016

  11. 0.74

    Value of neuropsychological testing, imaging, and CSF biomarkers for the differential diagnosis and prognosis of clinically ambiguous dementia

    Boutoleau-Bretonniere C, Lebouvier T, Delaroche O et al. · Journal of Alzheimer's disease : JAD · 2012

  12. 0.70

    The 12-Word Philadelphia Verbal Learning Test Performances in Older Adults: Brain MRI and Cerebrospinal Fluid Correlates and Regression-Based Normative Data

    Gifford KA, Liu D, Neal JE et al. · Dementia and geriatric cognitive disorders extra · 2018

  13. 0.70

    Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice

    Li W, Petersen RC, Algeciras-Schimnich A et al. · Mayo Clinic proceedings · 2024

  14. 0.68

    Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers

    Vercruysse O, Paquet C, Gabelle A et al. · Current Alzheimer research · 2018

  15. 0.54

    Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers

    Howell JC, Watts KD, Parker MW et al. · Alzheimer's research & therapy · 2017

06matter · motor10편

  1. 0.86

    SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage

    Faber I, Martinez ARM, de Rezende TJR et al. · NeuroImage. Clinical · 2018

  2. 0.82

    MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort

    Casanova F, Tian Q, Williamson DS et al. · Neurobiology of disease · 2024

  3. 0.82

    Striatal Atrophy in the Behavioural Variant of Frontotemporal Dementia: Correlation with Diagnosis, Negative Symptoms and Disease Severity

    Macfarlane MD, Jakabek D, Walterfang M et al. · PloS one · 2015

  4. 0.82

    Quantitative susceptibility mapping in beta-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study

    Tiepolt S, Rullmann M, Jochimsen TH et al. · European journal of radiology · 2020

  5. 0.81

    MR fingerprinting as a diagnostic tool in patients with frontotemporal lobe degeneration: A pilot study

    Keil VC, Bakoeva SP, Jurcoane A et al. · NMR in biomedicine · 2019

  6. 0.77

    Magnetic resonance imaging and histopathology in dementia, clinically of frontotemporal type

    Larsson E, Passant U, Sundgren PC et al. · Dementia and geriatric cognitive disorders · 2000

  7. 0.76

    MRI with diffusion tensor imaging post-mortem at 3.0 T in a patient with frontotemporal dementia

    Larsson EM, Englund E, Sjobeck M et al. · Dementia and geriatric cognitive disorders · 2004

  8. 0.72

    Central nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy-MRS and DTI study

    Dziadkowiak E, Koszewicz M, Podgorski P et al. · Frontiers in neurology · 2024

  9. 0.67

    Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study

    Sacchi L, Contarino VE, Siggillino S et al. · Journal of Alzheimer's disease : JAD · 2023

  10. 0.61

    EEG markers are associated to gray matter changes in thalamus and basal ganglia in subjects with mild cognitive impairment

    Moretti DV, Paternico D, Binetti G et al. · NeuroImage · 2012

07volume · thickness10편

  1. 0.76

    Accelerating cortical thinning: unique to dementia or universal in aging?

    Fjell AM, Westlye LT, Grydeland H et al. · Cerebral cortex (New York, N.Y. : 1991) · 2014

  2. 0.71

    Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia

    Bigler ED, Neeley ES, Miller MJ et al. · Journal of the International Neuropsychological Society : JINS · 2004

  3. 0.71

    A computational model to describe multi-regional brain architecture during neurodegeneration in Alzheimer's disease

    Li X, Rockall AG, Edison P et al. · Scientific reports · 2026

  4. 0.69

    Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status

    Reas ET, Triebswetter C, Banks SJ et al. · Alzheimer's research & therapy · 2024

  5. 0.66

    Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults

    Soldan A, Wang J, Pettigrew C et al. · Brain communications · 2024

  6. 0.62

    Emulating clinician-assigned diagnostic patterns of Alzheimer's disease in a tertiary neurology hospital using interpretable Bayesian machine learning

    Ahmed E, Rahman A, Yusuf A et al. · Journal of Alzheimer's disease reports · 2026

  7. 0.61

    Automatic MRI Volumetry Assisted Visual Assessment of the Medial Temporal Lobe in Clinical Dementia Work-Up

    Persson K, Rhodius-Meester HFM, Edwin TH et al. · Brain and behavior · 2025

  8. 0.57

    Association between mammillary body atrophy and memory impairment in retired athletes with a history of repetitive mild traumatic brain injury

    Miyata M, Takahata K, Sano Y et al. · Scientific reports · 2024

  9. 0.52

    Predicting the Emergence of Major Neurocognitive Disorder Within Three Months After a Stroke

    Aamodt EB, Schellhorn T, Stage E et al. · Frontiers in aging neuroscience · 2021

  10. 0.50

    Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia

    Koenig LN, Day GS, Salter A et al. · NeuroImage. Clinical · 2020

08plasma · white matter9편

  1. 0.86

    Integrated (18)F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders

    Li CH, Chen TF, Chiu MJ et al. · Frontiers in aging neuroscience · 2021

  2. 0.84

    White Matter Hyperintensities Moderate the Association Between Diabetes and Non-AD Brain Atrophy

    Cui J, Liu Z, Tan WY et al. · Diabetes care · 2026

  3. 0.81

    Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers

    Montembeault M, Brambati SM, Lamari F et al. · NeuroImage. Clinical · 2018

  4. 0.80

    Spatial and Temporal Distribution of White Matter Lesions in NOTCH2NLC-Related Neuronal Intranuclear Inclusion Disease

    Zhong S, Fei B, Liang J et al. · Neurology · 2025

  5. 0.79

    Serum long-chain omega-3 and omega-6 fatty acids differentially predict brain atrophy, white matter hyperintensities, and lacunes in individuals with cerebral small vessel disease with or without Alzheimer's disease

    Yedor LM, Chambers KO, Moran-Garrido M et al. · Journal of Alzheimer's disease : JAD · 2026

  6. 0.68

    Midlife plasma proteomic profiles indicate altered amyloid and tau processing in former elite rugby players

    Graham N, Zimmerman K, Hain J et al. · Journal of neurology, neurosurgery, and psychiatry · 2026

  7. 0.65

    Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging

    Bigler ED, Lowry CM, Kerr B et al. · Neuropsychology · 2003

  8. 0.56

    Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects

    Pereira JB, Janelidze S, Stomrud E et al. · Brain : a journal of neurology · 2021

  9. 0.55

    Plasma Biomarkers of Brain Injury and Their Association With Brain MRI and Cognition in Type 1 Diabetes

    Karger AB, Nasrallah IM, Braffett BH et al. · Diabetes care · 2024